Could Mean Platelet Volume Serve as a Prognostic Indicator for Outcomes in Cancer?
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
Early results demonstrate the potential of personalized 3D-printed shields for protecting healthy GI tissue in patients undergoing radiotherapy for prostate cancer.